NICE endorses breast-cancer metastasis analyzer from Sysmex

08/8/2013 | Clinica (subscription required)

Sysmex has received endorsement from the U.K.'s National Institute for Health and Care Excellence for its RD-100i OSNA technology. The recommendation applies for use of the device in diagnosing sentinel lymph node metastases in patients undergoing initial breast cancer surgery.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC